RSV Fusion Glycoprotein (F) Subunit Vaccine (Novartis)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRSV Fusion Glycoprotein (F) Subunit Vaccine (Novartis)
Drug Alias NameRSV fusion glycoprotein subunit vaccineRSV F subunit vaccineRSV-F protein vaccine
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A